Maesteg teen whose cancer returned weeks after remission has clinical trial hope

Maesteg teen whose cancer returned weeks after remission has clinical trial hope

A 14-year-old boy whose cancer returned just days after he was declared cancer-free is now receiving renewed hope thanks to a new clinical trial. Ethan Griffiths was initially diagnosed in January with Burkitt Lymphoma, a rapidly progressing form of non-Hodgkin lymphoma. Following treatment at Noah’s Ark Children’s Hospital, Ethan experienced a brief period of normalcy in May after completing chemotherapy and ringing the symbolic bell marking the end of his treatment.

However, this hope was short-lived. Shortly after a week at home, a biopsy revealed that Ethan’s cancer had returned aggressively. His father, Lloyd Griffiths, shared that Ethan had been in constant pain and had lost significant weight prior to his emergency surgery in January. Despite the challenging diagnosis, the family remains determined to fight and have enrolled Ethan in a clinical trial at Bristol Royal Hospital for Children that is testing two targeted drugs designed to treat relapsed or treatment-resistant B-cell non-Hodgkin lymphomas in young patients.

Ethan had endured six rounds of chemotherapy before initially being declared cancer-free, a milestone celebrated emotionally both at the hospital and with his rugby team. He had been relishing getting back to his usual activities like playing for Llangynwyd Rangers and enjoying time with friends. Unfortunately, as symptoms like abdominal pain and breathing difficulties returned, further tests confirmed the cancer’s return and growth. Lloyd emphasized the gravity of relapsed Burkitt Lymphoma, noting the condition’s potential resistance to treatments, but expressed cautious optimism about the trial’s 50% chance of success.

The trial is conducted across multiple UK hospitals, including centers in Bristol, Birmingham, and Manchester. Ethan recently began treatment through this program, which marked a new phase in his ongoing battle. Lloyd stressed the importance of focusing on small victories during such difficult times and highlighted the unwavering support from Ethan’s family, friends, and community. Meanwhile, Bridgend Athletic RFC has organized fundraising efforts to assist the family as they navigate these challenges. Should the experimental treatment fail, Ethan’s family remains committed to pursuing other options internationally to support his recovery

Read the full article from The BBC here: Read More